Company Performance: Arcturus Therapeutics' financial health, including revenue, earnings, and profitability, significantly impacts its stock price. Positive financial results usually lead to price increases, while negative ones cause declines. Pipeline Progress: Success in clinical trials for its mRNA-based therapeutics is crucial. Positive trial data typically boosts the stock, while setbacks or failures can lower it. Regulatory approvals also drive up the price. Market Sentiment: Overall investor confidence and market trends, particularly in the biotechnology sector, influence ARCT.ST. Positive market sentiment often lifts the stock, while negative sentiment can depress it. Competition: The activities of competitor companies developing similar therapies affect investor perception of Arcturus's market position. Successes or failures of competitors can indirectly influence ARCT.ST. Industry News: Major industry events, regulatory changes, or technological advancements in the mRNA field can impact investor sentiment towards Arcturus and other companies in the sector. Economic Conditions: Broader economic factors like inflation, interest rates, and economic growth can indirectly influence the stock price. Economic downturns often lead to decreased investment and lower stock prices.